European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia
Journal of Allergy and Clinical Immunology · 2024-12 · 154 (6) · 1391-1408
DOI: 10.1016/j.jaci.2024.07.031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024-12. Verfasst von Alexandra Y Kreins und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Infection Immunity…. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, UKRI MRC, Wellcome Trust.
Abstract (Originalsprache)
Congenital athymia is a life-limiting disorder due to rare inborn errors of immunity causing impaired thymus organogenesis or abnormal thymic stromal cell development and function. Athymic infants have a T-lymphocyte-negative, B-lymphocyte-positive, natural killer cell-positive immunophenotype with profound T-lymphocyte deficiency and are susceptible to severe infections and autoimmunity. Patients variably display syndromic features. Expanding access to newborn screening for severe combined immunodeficiency and T lymphocytopenia and broad genetic testing, including next-generation sequencing technologies, increasingly facilitate their timely identification. The recommended first-line treatment is allogeneic thymus transplantation, which is a specialized procedure available in Europe and the United States. Outcomes for athymic patients are best with early diagnosis and thymus transplantation before the development of infectious and inflammatory complications. These guidelines on behalf of the European Society for Immunodeficiencies provide a comprehensive review for clinicians who manage patients with inborn thymic stromal cell defects; they offer clinical practice recommendations focused on the diagnosis, investigation, risk stratification, and management of congenital athymia with the aim of improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Infection Immunity and Inflammation Research and Teaching Department, University College…
- Department of Paediatrics and Institute of Developmental and Regenerative Medicine, University of Oxford, Oxford, United Kingdom; Department of Clinical Immunology, Oxford University Hospitals NHS Foundation Trust, Oxfo…
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Paediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Depar…
- Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
- Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrens…
- San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Hospital, Milan, Italy; Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale Delle Ricerche (IRGB-CNR), Milan, Italy.
Förderung
- Swedish Research Council
- UKRI MRC
- Wellcome Trust
- Horizon Europe
Zitieren
APA
Kreins, A. Y., Dhalla, F., Flinn, A. M., Howley, E., Ekwall, O., Villa, A., Staal, F. J. T., Anderson, G., Gennery, A. R., Holländer, G. A., Davies, E. G., & European Society for Immunodeficiencies Clinical Working Party (2024). European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia. Journal of Allergy and Clinical Immunology, 154(6), 1391-1408. https://doi.org/10.1016/j.jaci.2024.07.031
Vancouver
Kreins AY, Dhalla F, Flinn AM, Howley E, Ekwall O, Villa A, et al. European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia. Journal of Allergy and Clinical Immunology. 2024;154(6):1391-1408. doi:10.1016/j.jaci.2024.07.031
BibTeX
@article{Kreins2024,
author = {Kreins, Alexandra Y and Dhalla, Fatima and Flinn, Aisling M and Howley, Evey and Ekwall, Olov and Villa, Anna and Staal, Frank J T and Anderson, Graham and Gennery, Andrew R and Holländer, Georg A and Davies, E Graham and European Society for Immunodeficiencies Clinical Working Party, European Society for Immunodeficiencies Clinical Working Party},
title = {European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
volume = {154},
number = {6},
pages = {1391--1408},
doi = {10.1016/j.jaci.2024.07.031}
}
EUVIMED